搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methylobacillus flagellatus 50S ribosomal protein L4 (rplD) CSB-YP627483MAAN
CSB-EP627483MAAN
CSB-BP627483MAAN
CSB-MP627483MAAN
CSB-EP627483MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus 50S ribosomal protein L7/L12 (rplL) CSB-YP627484MAAN
CSB-EP627484MAAN
CSB-BP627484MAAN
CSB-MP627484MAAN
CSB-EP627484MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP627485MAAN
CSB-EP627485MAAN
CSB-BP627485MAAN
CSB-MP627485MAAN
CSB-EP627485MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus Probable cytosol aminopeptidase (pepA) CSB-YP627486MAAN
CSB-EP627486MAAN
CSB-BP627486MAAN
CSB-MP627486MAAN
CSB-EP627486MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus UPF0042 nucleotide-binding protein Mfla_0145 (Mfla_0145) CSB-YP627487MAAN
CSB-EP627487MAAN
CSB-BP627487MAAN
CSB-MP627487MAAN
CSB-EP627487MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Cation/H (+) antiporter 24 (CHX24), partial CSB-YP627488DOA
CSB-EP627488DOA
CSB-BP627488DOA
CSB-MP627488DOA
CSB-EP627488DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombyx mori NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 CSB-YP627489BTT
CSB-EP627489BTT
CSB-BP627489BTT
CSB-MP627489BTT
CSB-EP627489BTT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes aegypti 60S ribosomal protein L5 (RpL5) CSB-YP627490AXQ
CSB-EP627490AXQ
CSB-BP627490AXQ
CSB-MP627490AXQ
CSB-EP627490AXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes aegypti 60S ribosomal protein L18 (RpL18) CSB-YP627491AXQ
CSB-EP627491AXQ
CSB-BP627491AXQ
CSB-MP627491AXQ
CSB-EP627491AXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes aegypti ATP synthase subunit a (mt:ATPase6), partial CSB-YP627492AXQ1
CSB-EP627492AXQ1
CSB-BP627492AXQ1
CSB-MP627492AXQ1
CSB-EP627492AXQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesophylla macconnelli NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP627493MBAB1
CSB-EP627493MBAB1
CSB-BP627493MBAB1
CSB-MP627493MBAB1
CSB-EP627493MBAB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uroderma bilobatum NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP627494UAAB1
CSB-EP627494UAAB1
CSB-BP627494UAAB1
CSB-MP627494UAAB1
CSB-EP627494UAAB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ectophylla alba NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP627495EAAP1
CSB-EP627495EAAP1
CSB-BP627495EAAP1
CSB-MP627495EAAP1
CSB-EP627495EAAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Thymidine kinase (TK), partial CSB-YP627496EEZ
CSB-EP627496EEZ
CSB-BP627496EEZ
CSB-MP627496EEZ
CSB-EP627496EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Portal protein BBRF1 (BBRF1), partial CSB-YP627497EEZ
CSB-EP627497EEZ
CSB-BP627497EEZ
CSB-MP627497EEZ
CSB-EP627497EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Micromonas pusilla reovirus Putative outer capsid protein VP9 (S9) CSB-YP627499MBAA
CSB-EP627499MBAA
CSB-BP627499MBAA
CSB-MP627499MBAA
CSB-EP627499MBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative beta-neurotoxin Td8 CSB-YP627500TOM
CSB-EP627500TOM
CSB-BP627500TOM
CSB-MP627500TOM
CSB-EP627500TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative beta-neurotoxin Td6 CSB-YP627501TOM
CSB-EP627501TOM
CSB-BP627501TOM
CSB-MP627501TOM
CSB-EP627501TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative beta-neurotoxin Td10 CSB-YP627502TOM
CSB-EP627502TOM
CSB-BP627502TOM
CSB-MP627502TOM
CSB-EP627502TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila tRNA modification GTPase MnmE (mnmE) CSB-YP627503PAAK
CSB-EP627503PAAK
CSB-BP627503PAAK
CSB-MP627503PAAK
CSB-EP627503PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>